Institutional investors purchased a net $322.8 thousand shares of CGIX during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 12.85% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 139.2 Thousand shares of Cancer Genetics Inc
EAM INVESTORS LLC Bought 117.9 Thousand shares of Cancer Genetics Inc
THE VANGUARD GROUP, INC. Bought 94.1 Thousand shares of Cancer Genetics Inc